Page last updated: 2024-10-30

memantine and Hebephrenic Schizophrenia

memantine has been researched along with Hebephrenic Schizophrenia in 1 studies

Research Excerpts

ExcerptRelevanceReference
" The duration of the study for each patient was 6 months, the target dosage of acatinol was 20 mg."2.79[The use of acatinol in the treatment of stable patients with schizophrenia with predominance of behaviour disorganization and subcatatonic features]. ( Arsenieva, TB; Beniashvili, AG; Burminsky, DS; Cheremin, RA; Kozhekin, IG; Lepilkina, TA; Morozova, MA; Onegina, EY; Potanin, SS; Rupchev, GE; Shvedova, AK; Yachmenev, VN, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morozova, MA1
Rupchev, GE1
Kozhekin, IG1
Arsenieva, TB1
Cheremin, RA1
Yachmenev, VN1
Onegina, EY1
Shvedova, AK1
Beniashvili, AG1
Burminsky, DS1
Lepilkina, TA1
Potanin, SS1

Trials

1 trial available for memantine and Hebephrenic Schizophrenia

ArticleYear
[The use of acatinol in the treatment of stable patients with schizophrenia with predominance of behaviour disorganization and subcatatonic features].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2014, Volume: 114, Issue:1

    Topics: Adult; Antipsychotic Agents; Dopamine Agents; Female; Humans; Male; Memantine; Middle Aged; Schizoph

2014